ES2094907T3 - Secuencias de adn que codifican para caracteristicas de virulencia de -s(streptococcus suis) y partes del mismo, polipeptidos y anticuerpos derivados de este y su uso para la diagnosis y la proteccion contra la infeccion por -s(s. suis) en mamiferos, incluyendo el ser humano. - Google Patents

Secuencias de adn que codifican para caracteristicas de virulencia de -s(streptococcus suis) y partes del mismo, polipeptidos y anticuerpos derivados de este y su uso para la diagnosis y la proteccion contra la infeccion por -s(s. suis) en mamiferos, incluyendo el ser humano.

Info

Publication number
ES2094907T3
ES2094907T3 ES92908242T ES92908242T ES2094907T3 ES 2094907 T3 ES2094907 T3 ES 2094907T3 ES 92908242 T ES92908242 T ES 92908242T ES 92908242 T ES92908242 T ES 92908242T ES 2094907 T3 ES2094907 T3 ES 2094907T3
Authority
ES
Spain
Prior art keywords
suis
polypeptides
antibodies derived
diagnosis
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92908242T
Other languages
English (en)
Inventor
Hilda Elizabeth Smith
Uri Vecht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Centraal Diergeneeskundig Instituut
Original Assignee
Stichting Centraal Diergeneeskundig Instituut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Centraal Diergeneeskundig Instituut filed Critical Stichting Centraal Diergeneeskundig Instituut
Application granted granted Critical
Publication of ES2094907T3 publication Critical patent/ES2094907T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A SECUENCIAS DE DNA QUE CODIFICAN POLIPEPTIDOS QUE SON CARACTERISTICOS PARA LA VIRULENCIA DE LA BACTERIA PATOGENA "STREPTOCOCCUS SUIS" Y PARTES DE LAS MISMAS, Y POLIPEPTIDOS Y ANTICUERPOS DERIVADOS DE LAS MISMAS. LAS SECUENCIAS CODIFICAN UN POLIPEPTIDOS DE ENTRE 90000 Y 120000 DALTONS O UN POLIPEPTIDO DE PESO MOLECULAR MAYOR QUE CONTIENE DICHO POLIPEPTIDO Y UN POLIPEPTIDO DE ENTRE 135000 Y 136000 DALTONS (PROTEINA RELACIONADA CON LA MURAMIDASA), O PARTES DEL MISMO. LAS SECUENCIAS MISMAS, Y TAMBIEN LOS POLIPEPTIDOS Y ANTICUERPOS DERIVADOS DE LAS MISMAS, SE USAN PARA LA DIAGNOSIS Y PROTECCION CONTRA LA INFECCION POR EL "S. SUIS" EN MAMIFEROS INCLUYENDO EL HOMBRE.
ES92908242T 1991-03-21 1992-03-19 Secuencias de adn que codifican para caracteristicas de virulencia de -s(streptococcus suis) y partes del mismo, polipeptidos y anticuerpos derivados de este y su uso para la diagnosis y la proteccion contra la infeccion por -s(s. suis) en mamiferos, incluyendo el ser humano. Expired - Lifetime ES2094907T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9100510A NL9100510A (nl) 1991-03-21 1991-03-21 Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens.

Publications (1)

Publication Number Publication Date
ES2094907T3 true ES2094907T3 (es) 1997-02-01

Family

ID=19859048

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92908242T Expired - Lifetime ES2094907T3 (es) 1991-03-21 1992-03-19 Secuencias de adn que codifican para caracteristicas de virulencia de -s(streptococcus suis) y partes del mismo, polipeptidos y anticuerpos derivados de este y su uso para la diagnosis y la proteccion contra la infeccion por -s(s. suis) en mamiferos, incluyendo el ser humano.

Country Status (14)

Country Link
US (1) US5610011A (es)
EP (1) EP0575497B1 (es)
JP (1) JP2776633B2 (es)
CN (1) CN1055500C (es)
AT (1) ATE143693T1 (es)
AU (1) AU659637B2 (es)
CA (1) CA2105057C (es)
DE (1) DE69214277T2 (es)
DK (1) DK0575497T3 (es)
ES (1) ES2094907T3 (es)
GR (1) GR3022052T3 (es)
NL (1) NL9100510A (es)
NZ (1) NZ242037A (es)
WO (1) WO1992016630A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
US5726016A (en) * 1995-01-18 1998-03-10 The Trustees Of The University Of Pennsylvania Compositions and methods for diagnosis of diseases associated with actinobacillus actinomycetemcomitans infection
ATE219146T1 (de) * 1995-01-30 2002-06-15 Lunamed Ag Antitumorpräparate, die eine lipoteichonsäure aus streptococcus enthalten
ES2512496T3 (es) 1998-07-22 2014-10-24 Stichting Dienst Landbouwkundig Onderzoek Vacunas y pruebas de diagnóstico de Streptococcus suis
EP1205552A1 (en) * 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Virulence of streptococci, involving ORFs from Streptococcus suis
US6905816B2 (en) * 2000-11-27 2005-06-14 Intelligent Medical Devices, Inc. Clinically intelligent diagnostic devices and methods
JP4275413B2 (ja) 2001-02-02 2009-06-10 イーデー−レーリスタット，インスティチュート フォール ディールハウデレイ エン ディールゲゾントヘイト ベー．フェー． ストレプトコッカス・スイスの環境的に調節された遺伝子
USRE47164E1 (en) 2005-09-02 2018-12-18 Valorisation-Recherche Limited Partnership Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
CN100388952C (zh) * 2006-04-25 2008-05-21 范红结 一种链球菌重组亚单位疫苗及其制备方法
CN100449005C (zh) * 2006-06-29 2009-01-07 中国检验检疫科学研究院动植物检疫研究所 应用于猪链球菌2型致病性检测的多重荧光pcr检测试剂及方法
CN100449006C (zh) * 2006-08-10 2009-01-07 中国检验检疫科学研究院动植物检疫研究所 应用于猪链球菌2型胞外因子(ef)荧光pcr检测的引物和探针序列
EP2023143A1 (en) * 2007-08-06 2009-02-11 Boehringer Ingelheim Vetmedica Gmbh Immunogenic streptococcus proteins
CN101613402B (zh) * 2008-06-25 2012-11-28 中国人民解放军军事医学科学院微生物流行病研究所 一种猪链球菌2型表面蛋白、其制备方法及用途
CN101613400B (zh) * 2008-06-25 2012-11-28 中国人民解放军军事医学科学院微生物流行病研究所 一种猪链球菌2型表面细胞壁蛋白、其制备方法及用途
CN101613399B (zh) * 2008-06-25 2012-11-28 中国人民解放军军事医学科学院微生物流行病研究所 一种猪链球菌2型表面蛋白、其制备方法及用途
MX2015013142A (es) * 2013-03-15 2016-05-18 Camas Inc Métodos y composiciones para reducir microorganismos en la orofaringe, nasofaringe y cavidades orales.
CN104762244B (zh) * 2015-02-04 2017-09-15 中国农业科学院哈尔滨兽医研究所 猪链球菌SBP_bac_5基因缺失株及其构建方法与应用
CN107805660B (zh) * 2017-12-08 2021-11-26 江汉大学 一种猪链球菌小种分离鉴定方法
GB2587228B (en) * 2019-09-20 2021-10-27 Protein Ark Ltd Biological sample purification apparatus, use of the same, and systems comprising the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784948A (en) * 1983-08-10 1988-11-15 The Rockefeller University Production of streptococcal m protein immunogens and molecular probes
CA2009708A1 (en) * 1989-02-13 1990-08-13 Jane D. Madonna Nucleic acid probe for the detection of salmonella human pathogens

Also Published As

Publication number Publication date
DE69214277T2 (de) 1997-03-20
AU659637B2 (en) 1995-05-25
CN1065490A (zh) 1992-10-21
EP0575497B1 (en) 1996-10-02
NZ242037A (en) 1997-03-24
DE69214277D1 (de) 1996-11-07
ATE143693T1 (de) 1996-10-15
EP0575497A1 (en) 1993-12-29
AU1546492A (en) 1992-10-21
GR3022052T3 (en) 1997-03-31
DK0575497T3 (da) 1996-11-18
CA2105057A1 (en) 1992-09-22
US5610011A (en) 1997-03-11
CA2105057C (en) 2000-05-02
CN1055500C (zh) 2000-08-16
WO1992016630A1 (en) 1992-10-01
JPH06505390A (ja) 1994-06-23
JP2776633B2 (ja) 1998-07-16
NL9100510A (nl) 1992-10-16

Similar Documents

Publication Publication Date Title
ES2094907T3 (es) Secuencias de adn que codifican para caracteristicas de virulencia de -s(streptococcus suis) y partes del mismo, polipeptidos y anticuerpos derivados de este y su uso para la diagnosis y la proteccion contra la infeccion por -s(s. suis) en mamiferos, incluyendo el ser humano.
MX9204685A (es) Secuencia de adn que codifica una proteina superficial externa (ospa) o derivado de la misma composicion de vacuna qe comprende tal proteina.
DE69636487D1 (de) Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
ATE118352T1 (de) Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits.
ATE358176T1 (de) Menschliche dnase
AR245778A1 (es) Secuencia de nucleotido que codifica una proteina de membrana exterior de neisseria meningitis y uso de dicha proteina en preparaciones de vacuna
DE68916932D1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
CY1112171T1 (el) Μτβ32α αντιγονο μυκοβακτηριδιου της φυματιωσης με απενεργοποιημενη δραστικη θεση και πρωτεϊνες συντηξης αυτου
ATE444360T1 (de) T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
EA200201280A1 (ru) Стрептококковые антигены
BR9914066A (pt) Polipeptìdio degradador de c3 de complemento humano de streptococcus pneumoniae
GB9219936D0 (en) Vaccines
DE3751727D1 (de) Polypeptide zur verwendung bei der diagnose von mycoplasmainfektionen bei schweinen, sowie rekombinant-dns-verfahren zur herstellung derselben
NO922421D0 (no) Collagenbindende protein, samt fremstilling derav
ES2072749T5 (es) Diagnostico de la hipertermia maligna porcina.
FI943146A0 (fi) Signaalipeptideistä vapaiden stafylokinaasien ilmentyminen
DE69122103D1 (de) Antigerinnungspeptide
TR199902609T2 (xx) Parazitlere kar�� koruyucu ba����kl���n �l��lmesi i�in y�ntem olarak bir eks vivo hayvan ya da y�kleme modeli ve bahsedilen y�ntemde koruyucu oldu�u g�sterilmi� a��lar.
DE69109126D1 (de) Impfstoff, geeignet für die bekämpfung von bordetella pertussis.
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
ES2095899T3 (es) Peptidos de la proteina gag de vih, su preparacion y uso.
DE69130675D1 (de) Klonierung und expression eines rhoptry-assoziierten proteins aus p. falciparum
CY1108864T1 (el) Ενωσεις για ανοσοθεραπεια και διαγνωση φυματιωσης και μεθοδοι χρησεις τους

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 575497

Country of ref document: ES